Park, A.; Govindaraj, C.; Xiang, S.D.; Halo, J.; Quinn, M.; Scalzo-Inguanti, K.; Plebanski, M.
Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy. Cancers 2012, 4, 581-600.
https://doi.org/10.3390/cancers4020581
AMA Style
Park A, Govindaraj C, Xiang SD, Halo J, Quinn M, Scalzo-Inguanti K, Plebanski M.
Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy. Cancers. 2012; 4(2):581-600.
https://doi.org/10.3390/cancers4020581
Chicago/Turabian Style
Park, Anthony, Chindu Govindaraj, Sue D. Xiang, Julene Halo, Michael Quinn, Karen Scalzo-Inguanti, and Magdalena Plebanski.
2012. "Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy" Cancers 4, no. 2: 581-600.
https://doi.org/10.3390/cancers4020581
APA Style
Park, A., Govindaraj, C., Xiang, S. D., Halo, J., Quinn, M., Scalzo-Inguanti, K., & Plebanski, M.
(2012). Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy. Cancers, 4(2), 581-600.
https://doi.org/10.3390/cancers4020581